VRTX vs BIIB: Which Stock is Better?

Side-by-side comparison of Vertex Pharmaceuticals Inc and Biogen Inc in 2026

Comparison Updated:

VRTX

Vertex Pharmaceuticals Inc

$496.83

BIIB

Biogen Inc

$191.82

Key Metrics Comparison

MetricVRTXBIIBWinner
Market Cap$126.19B$28.15BVRTX
P/E Ratio32.4721.82BIIB
EPS (TTM)$15.30$8.79VRTX
Revenue Growth0.1%-0.1%VRTX
Gross Margin53.7%78.9%BIIB

Analyze VRTX

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is VRTX or BIIB a better investment?

Comparing VRTX and BIIB: Vertex Pharmaceuticals Inc has a market cap of $126.19B while Biogen Inc has $28.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between VRTX and BIIB?

VRTX (Vertex Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: VRTX or BIIB?

Based on P/E ratios, BIIB trades at a lower multiple (21.8x vs 32.5x).

Which is growing faster: VRTX or BIIB?

VRTX has higher revenue growth at 0.1% vs -0.1% for BIIB.

Which company is more profitable: VRTX or BIIB?

Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 53.7% for VRTX.

Which is the larger company: VRTX or BIIB?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $126.19B compared to $28.15B for BIIB.

Should I buy VRTX or BIIB in 2026?

Both VRTX and BIIB have investment merit. VRTX trades at $496.83 while BIIB trades at $191.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between VRTX and BIIB stock?

Key differences: Market Cap ($126.19B vs $28.15B), P/E Ratio (32.5x vs 21.8x), Revenue Growth (0.1% vs -0.1%), Gross Margin (53.7% vs 78.9%).

Popular Stock Comparisons